{
    "clinical_study": {
        "@rank": "127834", 
        "arm_group": [
            {
                "arm_group_label": "Partial Brain Irradiation", 
                "arm_group_type": "Other", 
                "description": "Patients receiving partial brain irradiation for malignant or benign brain tumors."
            }, 
            {
                "arm_group_label": "Whole Brain Irradiation", 
                "arm_group_type": "Other", 
                "description": "Patients receiving whole brain irradiation for brain metastases."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study to determine if Magnetic Resonance Imaging (MRI) techniques  can detect\n      early changes in white matter (in the brain) and the blood-brain barrier resulting from\n      radiation therapy."
        }, 
        "brief_title": "MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Brain Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Brain Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients will be assigned to one of two groups based on the type of radiation they will be\n      receiving: whole brain irradiation or partial brain irradiation.  Patients will undergo\n      Magnetic Resonance Imaging (MRI) assessments, neurocognitive testing (Quality of Life and\n      Neuropsychological assessments), and clinical evaluation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients receiving partial brain irradiation for malignant or benign brain tumors\n             (including low-grade gliomas, high-grade gliomas, malignant meningioma, pituitary\n             adenomas, supratentorial meningioma, or craniopharyngiomas); or patients receiving\n             whole brain irradiation for brain metastases.\n\n          -  Patients must be 18 years of age or older\n\n          -  Patients must sign a study specific consent form approved by the Institutional Review\n             Board (IRB) of the University of Michigan prior to study entry.\n\n          -  Patients must have a neurological function class 1 or 2 with a Karnofsky performance\n             status (a scoring system used to quantify general well being and quality of life on a\n             scale of 100 to 0) of greater than or equal to 70.\n\n          -  Patients must have an expected life expectancy of greater than 6 months.\n\n        Exclusion Criteria:\n\n          -  Patients with a history of major medical illness or psychiatric impairment which, in\n             the investigator's opinion, will prevent administration of the protocol.\n\n          -  Patients who have had prior external beam irradiation to the brain or head/neck area\n             that will lead to overlap of the radiation field.\n\n          -  Patients should have no contraindications to having a contrast enhanced Magnetic\n             Resonance Imaging (MRI) scan.\n\n          -  Prisoners are excluded.\n\n          -  Pregnant women are excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01988675", 
            "org_study_id": "UMCC 2003.083"
        }, 
        "intervention": [
            {
                "arm_group_label": "Whole Brain Irradiation", 
                "intervention_name": "Whole Brain Irradiation", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "Partial Brain Irradiation", 
                "intervention_name": "Partial Brain Irradiation", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": [
                    "Partial Brain Irradiation", 
                    "Whole Brain Irradiation"
                ], 
                "intervention_name": "Neuropsychological Testing", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Partial Brain Irradiation", 
                    "Whole Brain Irradiation"
                ], 
                "intervention_name": "Quality of Life Assessment", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Partial Brain Irradiation", 
                    "Whole Brain Irradiation"
                ], 
                "description": "MRI Assessments include Diffusion Tensor Imaging (DTI)and Gd-DTPA (Diethylenetriamine Pentaacetic Acid - a radioactive tracer injected into the patient and viewed on images).", 
                "intervention_name": "Magnetic Resonance Imaging (MRI) Assessments", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 13, 2013", 
        "location": {
            "contact": {
                "email": "yuecao@umich.edu", 
                "last_name": "Yue Cao, Ph.D.", 
                "phone": "734-936-8695"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48109"
                }, 
                "name": "University of Michigan Hosptial"
            }, 
            "investigator": {
                "last_name": "Yue Cao, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier", 
        "overall_contact": {
            "email": "yuecao@umich.edu", 
            "last_name": "Yue Cao, Ph.D.", 
            "phone": "734-936-8695"
        }, 
        "overall_official": {
            "affiliation": "University of Michigan", 
            "last_name": "Yue Cao, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Linear mixed models will be used to relate Magnetic Resonance Imagining (MRI) changes and radiation dose.", 
            "measure": "Change in Magnetic Resonance Imagining (MRI) with different radiation dose at different timepoints.", 
            "safety_issue": "No", 
            "time_frame": "Baseline, at 3 weeks on radiation therapy (RT) (partial brain irradiation only),  last week of RT, 6 weeks post RT,  4 months post RT (whole brain irradiation only), 6 months post RT, 18 months post RT (partial brain irradiation only)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01988675"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan Cancer Center", 
            "investigator_full_name": "Yue Cao", 
            "investigator_title": "Professor of Radiation Oncology, Professor of Radiology, Medical School and Professor of Biomedical Engineering, College of Engineering", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Changes in Magnetic Resonance Imagining (MRI) assessments will be compared graphically to changes in neurocognitive function and clinical symptoms.  Parallel analysis will be conducted on each of the neurocognitive tests to determine if MRI assessments can identify patients at increased risk for later neurocognitive dysfunction.", 
            "measure": "Associate changes in Magnetic Resonance Imagining (MRI) assessments with changes in neurocognitive function and clinical symptoms, from baseline, and at different timepoints.", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 6 weeks post radiation therapy (RT), 4 months post RT (whole brain irradiation only), 6 months post RT, 18 months post RT (partial brain irradiation only)"
        }, 
        "source": "University of Michigan Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yue Cao", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2004", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}